semaglutide cardiovascular outcomes trial Effects of on Heart Failure in Diabetes and Chronic Kidney Disease in the FLOW semaglutide cardiovascular trial New Science

Generally, the 1 H-MRS studies show inconsistent findings due to different metabolites, age of the participants, the methodological techniques, and the brain region of interest

Glucose risk: repeated lows, wide glucose swings, or appetite changes with diabetes medication

Discontinuing glutathione supplementation may lead to a reverse of skin whitening, reduced antioxidant protection, and weakened immune function, so it is important to be mindful when making the decision to stop

Clinical Diabetes: a Publication of the American Diabetes Association, 38 (4), 390402

Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al

For US patients ordering a 90-day supply at a time, this matters a lot